<p>MIRA Pharmaceuticals, Inc.（纳斯达克代码：MIRA - 获取免费报告）在周三的交易中上涨了 2.1%。该公司的股价最高达到 1.55 美元，最后交易价格为 1.48 美元。在交易中大约有 418,018 股易手，比平均每日交易量 185,498 股增加了 125%。该股票之前的收盘价为 1.45 美元。</p>
<p>获取 <strong>MIRA Pharmaceuticals</strong> 的提醒：</p>
<h2>华尔街分析师预测增长</h2>
<p>多家券商最近对 MIRA 进行了评估。华尔街 Zen 在 11 月 22 日的报告中将 MIRA Pharmaceuticals 的股票评级从 “持有” 下调至 “卖出”。Weiss Ratings 在 12 月 10 日的研究报告中重申了对 MIRA Pharmaceuticals 的 “卖出（d-）” 评级。根据 MarketBeat 的数据显示，一位分析师对该股票给予了卖出评级，MIRA Pharmaceuticals 的共识评级为 “卖出”。</p>
<p><strong>查看我们关于 MIRA Pharmaceuticals 的最新报告</strong></p>
<h2>MIRA Pharmaceuticals 股票上涨 2.1%</h2>
<p>该股票的市值为 6198 万美元，市盈率为-0.97，贝塔值为 1.79。该公司的 50 日简单移动平均线为 1.47 美元，200 日简单移动平均线为 1.42 美元。</p>
<p>MIRA Pharmaceuticals（纳斯达克代码：MIRA - 获取免费报告）最近在 11 月 13 日发布了季度财报。该公司报告每股收益（EPS）为-1.18 美元，低于共识预期的-0.11 美元，差距为-1.07 美元。分析师预计 MIRA Pharmaceuticals, Inc.在当前财政年度的每股收益将为-0.6 美元。</p>
<h2>机构投资者对 MIRA Pharmaceuticals 的看法</h2>
<p>几家机构投资者最近对 MIRA 的持仓进行了调整。第一美洲银行在第三季度将其在 MIRA Pharmaceuticals 的持仓增加了 150.0%。第一美洲银行现在拥有 50,000 股该公司的股票，价值 68,000 美元，此前在上个季度又购买了 30,000 股。Two Sigma Investments LP 在第三季度将其在 MIRA Pharmaceuticals 的股份增加了 129.8%。Two Sigma Investments LP 现在拥有 45,703 股该公司的股票，价值 62,000 美元，此前在此期间又购买了 25,816 股。国际资产投资管理公司在第二季度购买了 MIRA Pharmaceuticals 的新头寸，价值约 42,000 美元。Creative Planning 在第二季度购买了 MIRA Pharmaceuticals 的新头寸，价值约 27,000 美元。最后，XTX Topco Ltd 在第二季度购买了 MIRA Pharmaceuticals 的新股份，价值约 26,000 美元。对冲基金和其他机构投资者持有该公司 35.16% 的股票。</p>
<h2>MIRA Pharmaceuticals 公司简介</h2>
<p>（获取免费报告）</p>
<p>MIRA Pharmaceuticals, Inc.是一家处于临床前阶段的制药开发公司，拥有两个神经科学项目，针对一系列神经和精神疾病。该公司拥有 Ketamir-2 的美国、加拿大和墨西哥独占权，这是一种正在研究的口服氯胺酮类似物，旨在为正在与难治性抑郁症、伴有自杀意念的重度抑郁症和创伤后应激障碍作斗争的个人提供超快速的抗抑郁效果。</p>
<h2>特色文章</h2>
<ul>
<li>我们更看好的五只股票超过 MIRA Pharmaceuticals</li>
<li>工业产品股票投资</li>
<li>在上涨 35% 后，分析师关注铜巨头 Freeport 的更多上涨空间</li>
<li>FAANG 股票是什么，它们是好的投资吗？</li>
<li>为什么 SpaceX 的 IPO 可能成为 GOOGL 股票的主要催化剂</li>
<li>FTSE 100 指数是什么？</li>
<li>Upwork 能否维持其复苏？看涨和看跌的理由</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 MIRA Pharmaceuticals 吗？</h2>
<p>在你考虑 MIRA Pharmaceuticals 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 MIRA Pharmaceuticals 并不在名单上。</p>
<p>虽然 MIRA Pharmaceuticals 目前在分析师中被评为卖出评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

MIRA

<p>MIRA Pharmaceuticals (NASDAQ:MIRA) 的股票在交易中上涨了 2.1%，最高达到 1.55 美元，最后交易价格为 1.48 美元。交易量比平均水平增加了 125%。尽管股价上涨，分析师已将该股票评级下调至 “卖出”。公司报告了季度亏损，未能达到预期。机构投资者已调整其持仓，持有该股票的比例为 35.16%。MIRA 专注于开发神经系统疾病的治疗方案</p>

<p>MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA - Get Free Report) rose 2.1% during trading on Wednesday . The company traded as high as $1.55 and last traded at $1.48. Approximately 418,018 shares changed hands during trading, an increase of 125% from the average daily volume of 185,498 shares. The stock had previously closed at $1.45.</p>
<div class="lb-trans"><p>MIRA Pharmaceuticals, Inc.（纳斯达克代码：MIRA - 获取免费报告）在周三的交易中上涨了 2.1%。该公司的股价最高达到 1.55 美元，最后交易价格为 1.48 美元。在交易中大约有 418,018 股易手，比平均每日交易量 185,498 股增加了 125%。该股票之前的收盘价为 1.45 美元。</p>
</div><p>Get <strong>MIRA Pharmaceuticals</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>MIRA Pharmaceuticals</strong> 的提醒：</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>A number of brokerages recently weighed in on MIRA. Wall Street Zen downgraded shares of MIRA Pharmaceuticals from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a report on Saturday, November 22nd. Weiss Ratings reiterated a &#34;sell (d-)&#34; rating on shares of MIRA Pharmaceuticals in a research note on Wednesday, December 10th. One analyst has rated the stock with a Sell rating, According to MarketBeat, MIRA Pharmaceuticals has a consensus rating of &#34;Sell&#34;.</p>
<div class="lb-trans"><p>多家券商最近对 MIRA 进行了评估。华尔街 Zen 在 11 月 22 日的报告中将 MIRA Pharmaceuticals 的股票评级从 “持有” 下调至 “卖出”。Weiss Ratings 在 12 月 10 日的研究报告中重申了对 MIRA Pharmaceuticals 的 “卖出（d-）” 评级。根据 MarketBeat 的数据显示，一位分析师对该股票给予了卖出评级，MIRA Pharmaceuticals 的共识评级为 “卖出”。</p>
</div><p><strong>Check Out Our Latest Report on MIRA Pharmaceuticals</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 MIRA Pharmaceuticals 的最新报告</strong></p>
</div><h2>MIRA Pharmaceuticals Stock Up 2.1%</h2>
<div class="lb-trans"><h2>MIRA Pharmaceuticals 股票上涨 2.1%</h2>
</div><p>The stock has a market cap of $61.98 million, a P/E ratio of -0.97 and a beta of 1.79. The business's 50-day simple moving average is $1.47 and its two-hundred day simple moving average is $1.42.</p>
<div class="lb-trans"><p>该股票的市值为 6198 万美元，市盈率为-0.97，贝塔值为 1.79。该公司的 50 日简单移动平均线为 1.47 美元，200 日简单移动平均线为 1.42 美元。</p>
</div><p>MIRA Pharmaceuticals (NASDAQ:MIRA - Get Free Report) last posted its quarterly earnings results on Thursday, November 13th. The company reported ($1.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($1.07). Analysts anticipate that MIRA Pharmaceuticals, Inc. will post -0.6 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>MIRA Pharmaceuticals（纳斯达克代码：MIRA - 获取免费报告）最近在 11 月 13 日发布了季度财报。该公司报告每股收益（EPS）为-1.18 美元，低于共识预期的-0.11 美元，差距为-1.07 美元。分析师预计 MIRA Pharmaceuticals, Inc.在当前财政年度的每股收益将为-0.6 美元。</p>
</div><h2>Institutional Investors Weigh In On MIRA Pharmaceuticals</h2>
<div class="lb-trans"><h2>机构投资者对 MIRA Pharmaceuticals 的看法</h2>
</div><p>Several institutional investors have recently made changes to their positions in MIRA. First American Bank grew its position in shares of MIRA Pharmaceuticals by 150.0% in the third quarter. First American Bank now owns 50,000 shares of the company's stock valued at $68,000 after purchasing an additional 30,000 shares in the last quarter. Two Sigma Investments LP boosted its stake in MIRA Pharmaceuticals by 129.8% in the 3rd quarter. Two Sigma Investments LP now owns 45,703 shares of the company's stock worth $62,000 after purchasing an additional 25,816 shares during the period. International Assets Investment Management LLC purchased a new position in MIRA Pharmaceuticals during the 2nd quarter valued at about $42,000. Creative Planning purchased a new position in MIRA Pharmaceuticals during the 2nd quarter valued at about $27,000. Finally, XTX Topco Ltd bought a new stake in shares of MIRA Pharmaceuticals during the second quarter valued at about $26,000. Hedge funds and other institutional investors own 35.16% of the company's stock.</p>
<div class="lb-trans"><p>几家机构投资者最近对 MIRA 的持仓进行了调整。第一美洲银行在第三季度将其在 MIRA Pharmaceuticals 的持仓增加了 150.0%。第一美洲银行现在拥有 50,000 股该公司的股票，价值 68,000 美元，此前在上个季度又购买了 30,000 股。Two Sigma Investments LP 在第三季度将其在 MIRA Pharmaceuticals 的股份增加了 129.8%。Two Sigma Investments LP 现在拥有 45,703 股该公司的股票，价值 62,000 美元，此前在此期间又购买了 25,816 股。国际资产投资管理公司在第二季度购买了 MIRA Pharmaceuticals 的新头寸，价值约 42,000 美元。Creative Planning 在第二季度购买了 MIRA Pharmaceuticals 的新头寸，价值约 27,000 美元。最后，XTX Topco Ltd 在第二季度购买了 MIRA Pharmaceuticals 的新股份，价值约 26,000 美元。对冲基金和其他机构投资者持有该公司 35.16% 的股票。</p>
</div><h2>MIRA Pharmaceuticals Company Profile</h2>
<div class="lb-trans"><h2>MIRA Pharmaceuticals 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>MIRA Pharmaceuticals, Inc operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder.</p>
<div class="lb-trans"><p>MIRA Pharmaceuticals, Inc.是一家处于临床前阶段的制药开发公司，拥有两个神经科学项目，针对一系列神经和精神疾病。该公司拥有 Ketamir-2 的美国、加拿大和墨西哥独占权，这是一种正在研究的口服氯胺酮类似物，旨在为正在与难治性抑郁症、伴有自杀意念的重度抑郁症和创伤后应激障碍作斗争的个人提供超快速的抗抑郁效果。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>特色文章</h2>
</div><ul>
<li>Five stocks we like better than MIRA Pharmaceuticals</li>
<li>Industrial Products Stocks Investing</li>
<li>Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport</li>
<li>What Are the FAANG Stocks and Are They Good Investments?</li>
<li>Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock</li>
<li>What is the FTSE 100 index?</li>
<li>Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过 MIRA Pharmaceuticals</li>
<li>工业产品股票投资</li>
<li>在上涨 35% 后，分析师关注铜巨头 Freeport 的更多上涨空间</li>
<li>FAANG 股票是什么，它们是好的投资吗？</li>
<li>为什么 SpaceX 的 IPO 可能成为 GOOGL 股票的主要催化剂</li>
<li>FTSE 100 指数是什么？</li>
<li>Upwork 能否维持其复苏？看涨和看跌的理由</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in MIRA Pharmaceuticals Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 MIRA Pharmaceuticals 吗？</h2>
</div><p>Before you consider MIRA Pharmaceuticals, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 MIRA Pharmaceuticals 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MIRA Pharmaceuticals wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 MIRA Pharmaceuticals 并不在名单上。</p>
</div><p>While MIRA Pharmaceuticals currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 MIRA Pharmaceuticals 目前在分析师中被评为卖出评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

MIRA Pharmaceuticals（NASDAQ:MIRA）股价上涨 2.1% - 事情经过如下